Kestrel Investment Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Hold
139,850
1.89% 24
2026
Q1
$1.96M Sell
139,850
-1,200
-0.9% -$16.2K 1.17% 35
2025
Q4
$1.58M Sell
141,050
-5,000
-3% -$57.2K 0.9% 36
2025
Q3
$1.69M Hold
146,050
0.95% 38
2025
Q2
$1.79M Sell
146,050
-6,900
-5% -$86.8K 1.07% 36
2025
Q1
$2.19M Hold
152,950
1.34% 32
2024
Q4
$2.44M Hold
152,950
1.34% 30
2024
Q3
$3.6M Buy
152,950
+8,500
+6% +$194K 2.07% 23
2024
Q2
$2.88M Hold
144,450
1.91% 25
2024
Q1
$2.88M Sell
144,450
-1,100
-0.8% -$21.3K 1.92% 27
2023
Q4
$3.27M Buy
+145,550
New +$3M 2.21% 22

Other funds holding AVNS

Kestrel Investment Management's AVNS Position: Q2 2026 in Review

Kestrel Investment Management held its Avanos Medical (AVNS) position steady in Q2 2026 at 139,850 shares worth $3.48M. The position accounts for 1.89% of the portfolio, ranked #24.

Kestrel Investment Management first reported a position in AVNS in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.6M in Q3 2024. 94 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Kestrel Investment Management held 139,850 shares of Avanos Medical worth $3.48M as of Q2 2026.
  • Kestrel Investment Management left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up 1.89% of Kestrel Investment Management's portfolio in Q2 2026, its #24 holding.
  • Kestrel Investment Management first reported a position in Avanos Medical in Q4 2023 and has held it in 11 quarters since.
  • Kestrel Investment Management's Avanos Medical position peaked at $3.6M in Q3 2024.
  • 94 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Kestrel Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.